Turkey Regulatory Update: New Center To Raise Local Study Quality
This article was originally published in PharmAsia News
A new center for bioequivalence and clinical studies has opened at the University of Istanbul, and a major stem cell project is calling for more donors. New data on organ transplants have been released and the SGK has added four products to the reimbursement list and set upper limits for two imported drugs.
Register for our free email digests: